Preparation method of three-layer core-shell structure drug carrier with near-infrared light remote response
A technology of near-infrared light and shell structure, which is applied to medical preparations with non-active ingredients, medical preparations containing active ingredients, and pharmaceutical formulas, etc. It can solve the problem of simultaneous cell imaging, photokinetic therapy, and light-controlled drug release. To achieve the effect of avoiding drug resistance and drug resistance of cancer cells, high precision of controlled release, and guaranteed curative effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0026] Embodiment 1: The preparation method of a three-layer core-shell structure drug carrier with near-infrared light remote response in this embodiment is specifically carried out according to the following steps:
[0027] 1. NaYF 4 : Yb / Er upconversion nanoparticles are dispersed in cyclohexane to obtain upconversion nanoparticle cores;
[0028] 2. Dissolve the surfactant CO-520 in cyclohexane at room temperature and stir magnetically for 15 to 30 minutes to obtain a mixed solution. Add the up-conversion nanoparticle core, photosensitizer and ammonia water obtained in step 1 to the mixed solution at room temperature. Stir at low temperature for 20min to 40min; then add tetraethoxysilane dropwise, stir at room temperature for 20h to 26h, centrifuge to obtain a solid, wash the solid with ethanol for 3 to 5 times, and then disperse it in deionized water to obtain a coating Upconverting nanoparticles with photosensitizers;
[0029] 3. Add the up-converting nanoparticles coat...
specific Embodiment approach 2
[0037] Embodiment 2: This embodiment differs from Embodiment 1 in that the volume ratio of the surfactant CO-520 described in step 2 to cyclohexane is 1 mg:(0.01-0.02) mL. Other steps and parameters are the same as those in the first embodiment.
specific Embodiment approach 3
[0038] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is that the quality of the surfactant CO-520 described in step two and the up-conversion nanoparticle core volume ratio obtained in step one are 1mg: (0.01~ 0.02) μL. Other steps and parameters are the same as those in Embodiment 1 or 2.
PUM
Property | Measurement | Unit |
---|---|---|
size | aaaaa | aaaaa |
pore size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com